VIP and colonic neoplasm: In the current study, we demonstrated that VIP antagonist enhanced M1 gene expression and phagocytosis of CT26 colon cancer cells in mouse macrophage RAW264.7 cells incubated with conditioned medium derived from CT26 cells.